Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643526 · ClinicalTrials.gov registry record · Early Phase 1
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
A Early Phase 1 study, sponsored by Centocor.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 68
- Enrollment target
NCT00643526 is a Early Phase 1 study that has completed, run by Centocor. The registered enrollment target is 68 participants.
The verdict
NCT00643526, a Early Phase 1 study, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate how well the autoinjector works in a group of people who are likely to use the autoinjector for injecting their medicine in the future. However, no active medicine is given by the autoinjector.
Interventions
- DEVICE Pre-filled Auto-injector Containing Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00643526
The ClinicalTrials.gov registry entry for NCT00643526 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centocor, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pre-filled Auto-injector Containing Placebo is the first listed.
NCT00643526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00643526 about?
NCT00643526 is a clinical study titled "A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector". The main purpose of this study is to evaluate how well the autoinjector works in a group of people who are likely to use the autoinjector for injecting their medicine in the future. However, no active medicine is given by the autoinjector.
What is the current status of trial NCT00643526?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 68 participants. The study started on 2007-12. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00643526?
The interventions under investigation include: Pre-filled Auto-injector Containing Placebo (DEVICE).
Who is sponsoring clinical trial NCT00643526?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.